accedi-icon

Investigator Calls

Share on facebook
Share on twitter

In the 2013 – 2015 three-year period, Fondazione Celiacha [The Celiac Foundation] was committed to funding scientific research conducted by the Italian “senior researcher” community. The FC Investigator Grants were launched for:

3 editions

from 2013 to 2015 with a total allocation of:

€ 1.500.000

in 3 years

 10

Funded Research Projects

Celiac disease was the main area of the funded projects, followed by 30% projects in other areas including dermatitis herpetiformis and non-celiac wheat sensitivity

THE RESEARCH TOPICS ADMITTED TO THE INVESTIGATOR GRANTS ARE CELIAC DISEASE, DERMATITIS HERPETIFORMIS AND OTHER GLUTEN –RELATED DISEASES, THE RESEARCH AREAS RANGE FROM BIOMEDICAL TO FOOD TECHNOLOGY.

Selection process

The project selection process and the peer review evaluation: objectivity and transparency

The Peer Reviewers

The proposals complying with the requirements of the fc call are sent to the international reviewers (peer reviewers), noted and competent researchers in the field of celiac disease and dermatitis herpetiformis.

3 Reviewers​

Each proposal is evaluated by three reviewers individually, according to competence and in the absence of conflict of interests.

OBJECTIVES

The purpose of the FC Investigator Grants is funding the best Italian research on celiac disease, dermatitis herpetiformis and other gluten-related diseases, carried out by senior researchers with proven experience. The Research Projects may have 1 year, 2 or 3 years duration, and are co-funded by FC, including consumables and reagents, the circulation of the results by the Principal Investigator (PI) at national and international conferences, the salary of auxiliary staff.
Most of the founded projects have now been completed, leading to the publication in international scientific journals and in the  proceedings of national and international conferences.

Research priorities

  • Identification of new pathogenic mechanisms
  • Development of new treatments, and the improvement of existing cures
  • Biological and pathophysiological mechanisms of the disease
  • Interaction between environmental risk factors, genetic profiles and biomarkers, including studies on the toxic components of gluten
  • Innovation of clinical methodologies
  • Improvement in quality of life and diagnostic and therapeutic efficiency, including the innovation of food products for celiacs and improvement in the quality and safety of gluten-free food

The main evaluation criteria

  • Proximity to cure and patient quality of life
  • Scientific value and feasibility
  • Clearness of the Proposal’s purposes
  • Impact on improvement and understanding of the disease and its treatment
  • Innovation and originality
Share on facebook
Share on twitter
Torna al sito regionale

Questo sito web utilizza cookies tecnici e di terze parti, anche di analisi statistica, al fine di migliorare l’esperienza di navigazione e le funzionalità. I cookie di analisi possono essere trattati per fini non tecnici dalle terze parti. Per avere maggiori informazioni e negare il consenso ai cookies clicca qui